ID

38582

Descrição

A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants; ODM derived from: https://clinicaltrials.gov/show/NCT01900652

Link

https://clinicaltrials.gov/show/NCT01900652

Palavras-chave

Versões (1)
  1. 24/10/2019 24/10/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

24 de outubro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Carcinoma, Non-Small-Cell Lung NCT01900652

Inglês

Eligibility Carcinoma, Non-Small-Cell Lung NCT01900652

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of metastatic stage iv nsclc
Descrição

Non-Small Cell Lung Carcinoma TNM clinical staging

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
at least 1 measurable extra-central nervous system (cns) lesion
Descrição

Measurable lesion Quantity | Exception Central nervous system lesion

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0742468
documented radiographic progression while on continuous treatment with erlotinib monotherapy
Descrição

Disease Progression Radiography | erlotinib

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0034571
UMLS CUI [2]
C1135135
objective clinical benefit from erlotinib treatment as defined by either documented partial or complete response or stable disease ≥6 months or, if most recent erlotinib treatment has been initiated based on documented epidermal growth factor receptor mutation (egfrmt) status, at least 12 weeks stable disease
Descrição

Benefit Clinical Due to Erlotinib | Partial response | In complete remission | Stable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0814225
UMLS CUI [1,2]
C0205210
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C1135135
UMLS CUI [2]
C1521726
UMLS CUI [3]
C0677874
UMLS CUI [4]
C0677946
determined to be met diagnostic positive (+)
Descrição

MET Positive

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1417123
UMLS CUI [1,2]
C1514241
availability of a tumor sample post-erlotinib progression
Descrição

Availability of Tumor tissue sample | Disease Progression | Status post Erlotinib

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0475358
UMLS CUI [2]
C0242656
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C1135135
eastern cooperative oncology group (ecog) performance status ≤2
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
have adequate organ function
Descrição

Organ function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
are currently enrolled in, or discontinued within the last 30 days from, a clinical trial involving an investigational product or non-approved use of a drug or device
Descrição

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
have previously been treated with ly2875358 or any other met-targeting experimental therapeutic
Descrição

LY2875358 | Targeted Therapy MET

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2987383
UMLS CUI [2,1]
C2985566
UMLS CUI [2,2]
C1417123
have a serious concomitant systemic disorder or significant cardiac disease
Descrição

Comorbidity Systemic Serious | Heart Disease

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0205404
UMLS CUI [2]
C0018799
have interstitial pneumonia or interstitial fibrosis of the lung or have pleural effusion, pericardial fluids or ascites, requiring drainage every other week or more frequently
Descrição

Pneumonia, Interstitial | Interstitial lung fibrosis | Pleural effusion | Pericardial effusion | Ascites | Requirement Drainage Frequency

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0206061
UMLS CUI [2]
C3887486
UMLS CUI [3]
C0032227
UMLS CUI [4]
C0031039
UMLS CUI [5]
C0003962
UMLS CUI [6,1]
C1514873
UMLS CUI [6,2]
C0013103
UMLS CUI [6,3]
C0439603
have a history of another malignancy except for basal or squamous cell skin cancer and/or in situ carcinoma of the cervix, or other solid tumors treated curatively and without evidence of recurrence for at least 3 years prior to the study
Descrição

Cancer Other | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin | Exception Carcinoma in situ of uterine cervix | Exception Curative treatment Solid Neoplasm | Exception Recurrent disease Free Duration

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1273390
UMLS CUI [5,3]
C0280100
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0277556
UMLS CUI [6,3]
C0332296
UMLS CUI [6,4]
C0449238
have major surgery less than 2 weeks prior initiation of study treatment therapy
Descrição

Major surgery

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0679637
pregnant or lactating women
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
have symptomatic cns metastasis
Descrição

CNS metastases Symptomatic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0231220
Voltar ao início da página

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT01900652

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging
Item
diagnosis of metastatic stage iv nsclc
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Measurable lesion Quantity | Exception Central nervous system lesion
Item
at least 1 measurable extra-central nervous system (cns) lesion
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0742468 (UMLS CUI [2,2])
Disease Progression Radiography | erlotinib
Item
documented radiographic progression while on continuous treatment with erlotinib monotherapy
boolean
C0242656 (UMLS CUI [1,1])
C0034571 (UMLS CUI [1,2])
C1135135 (UMLS CUI [2])
Benefit Clinical Due to Erlotinib | Partial response | In complete remission | Stable Disease
Item
objective clinical benefit from erlotinib treatment as defined by either documented partial or complete response or stable disease ≥6 months or, if most recent erlotinib treatment has been initiated based on documented epidermal growth factor receptor mutation (egfrmt) status, at least 12 weeks stable disease
boolean
C0814225 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C1135135 (UMLS CUI [1,4])
C1521726 (UMLS CUI [2])
C0677874 (UMLS CUI [3])
C0677946 (UMLS CUI [4])
MET Positive
Item
determined to be met diagnostic positive (+)
boolean
C1417123 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
Availability of Tumor tissue sample | Disease Progression | Status post Erlotinib
Item
availability of a tumor sample post-erlotinib progression
boolean
C0470187 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C1135135 (UMLS CUI [3,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status ≤2
boolean
C1520224 (UMLS CUI [1])
Organ function
Item
have adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
are currently enrolled in, or discontinued within the last 30 days from, a clinical trial involving an investigational product or non-approved use of a drug or device
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
LY2875358 | Targeted Therapy MET
Item
have previously been treated with ly2875358 or any other met-targeting experimental therapeutic
boolean
C2987383 (UMLS CUI [1])
C2985566 (UMLS CUI [2,1])
C1417123 (UMLS CUI [2,2])
Comorbidity Systemic Serious | Heart Disease
Item
have a serious concomitant systemic disorder or significant cardiac disease
boolean
C0009488 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0018799 (UMLS CUI [2])
Pneumonia, Interstitial | Interstitial lung fibrosis | Pleural effusion | Pericardial effusion | Ascites | Requirement Drainage Frequency
Item
have interstitial pneumonia or interstitial fibrosis of the lung or have pleural effusion, pericardial fluids or ascites, requiring drainage every other week or more frequently
boolean
C0206061 (UMLS CUI [1])
C3887486 (UMLS CUI [2])
C0032227 (UMLS CUI [3])
C0031039 (UMLS CUI [4])
C0003962 (UMLS CUI [5])
C1514873 (UMLS CUI [6,1])
C0013103 (UMLS CUI [6,2])
C0439603 (UMLS CUI [6,3])
Cancer Other | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin | Exception Carcinoma in situ of uterine cervix | Exception Curative treatment Solid Neoplasm | Exception Recurrent disease Free Duration
Item
have a history of another malignancy except for basal or squamous cell skin cancer and/or in situ carcinoma of the cervix, or other solid tumors treated curatively and without evidence of recurrence for at least 3 years prior to the study
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C1273390 (UMLS CUI [5,2])
C0280100 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0277556 (UMLS CUI [6,2])
C0332296 (UMLS CUI [6,3])
C0449238 (UMLS CUI [6,4])
Major surgery
Item
have major surgery less than 2 weeks prior initiation of study treatment therapy
boolean
C0679637 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
CNS metastases Symptomatic
Item
have symptomatic cns metastasis
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial